Table 2. Patient participants’ demographic and baseline characteristics (n=143).
| Breast cancer | Gynecological cancer | Lung Cancer | ||||
|
|
|
|
||||
| n | % | n | % | n | % | |
| Total | 47 | 100 | 47 | 100 | 47 | 100 |
| Age (year) | ||||||
| mean | 48.8 | 45.9 | 55.5 | |||
| standard deviation | 11.3 | 11.5 | 10.4 | |||
| range | 26-68 | 19-72 | 32-71 | |||
| Education | ||||||
| compulsory | 4 | 9 | 7 | 15 | 7 | 14 |
| junior school | 8 | 17 | 9 | 19 | 12 | 25 |
| senior school | 16 | 34 | 14 | 30 | 12 | 25 |
| diploma | 13 | 28 | 9 | 19 | 8 | 16 |
| university | 6 | 13 | 8 | 17 | 10 | 20 |
| Occupation | ||||||
| agriculture | 1 | 2 | 3 | 6 | 3 | 6 |
| industry | 5 | 11 | 5 | 11 | 6 | 12 |
| office work | 17 | 36 | 23 | 49 | 16 | 33 |
| student | 0 | 3 | 6 | 0 | ||
| service | 2 | 4 | 4 | 9 | 3 | 6 |
| housewife | 2 | 4 | 0 | 0 | ||
| pensioner | 18 | 38 | 7 | 15 | 19 | 39 |
| unemployed | 0 | 0 | 1 | 2 | ||
| other | 1 | 2 | 2 | 4 | 1 | 2 |
| Karnofsky Performance Status* | ||||||
| <70 | 8 | 17 | 12 | 26 | 5 | 10 |
| 70+ | 39 | 83 | 35 | 75 | 44 | 90 |
| Extent of disease | ||||||
| local | 25 | 53 | 14 | 30 | 7 | 14 |
| local regional | 16 | 34 | 20 | 43 | 18 | 37 |
| distance metastasis | 6 | 13 | 13 | 28 | 24 | 49 |
| Treatment | ||||||
| chemotherapy | 12 | 26 | 8 | 17 | 36 | 75 |
| chemotherapy + radiotherapy | 0 | 0 | 6 | 12 | ||
| chemotherapy + surgery | 32 | 68 | 38 | 81 | 4 | 8 |
| chemotherapy + radiation + surgery | 0 | 1 | 2 | 1 | 2 | |
| radiotherapy + surgery | 3 | 6 | 0 | 2 | 4 | |
* The Karnofsky Performance Status (KPS) is a global assessment of a patient’s self-care and ambulation abilities. The KPS categorizes a patient’s activity level using an 11-point ordinal level scale, ranging from 0 “dead” to 100 “normal activities with no signs or symptoms.”